Knobbe Martens

Thank you to MedTech Strategist for having Knobbe Martens partners Paul Conover and Irfan Lateef at Day 2 of the Innovation Summit in San Diego. ? Paul and Irfan presented “IP Trends in Medical Devices,” covering both transactions and litigation strategies in the field. ? #KnobbeMartens #IPLaw #MedicalDevices #InnovationSanDiego

Congratulations to Knobbe Martens partners Stephen Jensen and Joseph Re, who have been named to the OC500, Orange County Business Journal’s annual list of “the 500 most influential people in Orange County.” Steve and Joseph were both recognized for their roles in leading the Knobbe Martens teams representing Orange County-based health technology company Masimo Corporation in a series of litigation matters against Apple, Inc, including securing an import ban on Apple watches that were found to infringe Masimo’s patented pulse oximetry technology. Read more and find their full profiles here: https://lnkd.in/gcKDtaCu #KnobbeMartens #IPLaw #OC500

“Teva v. Amneal Oral Arguments and Claim Construction Order: Recent Developments in the Ongoing Debate Over the Orange Book Listing of Device Patents.” Read our latest Medical Devices Blog post by Sophia Zahn and Joseph Reisman here: https://lnkd.in/g-nijWA3 #KnobbeMartens #IPLaw #MedicalDevices

“Settlements Don’t Close the Door: Antitrust Claims Follow IPR Challenges in Life Sciences.” Read our latest Life Sciences Blog post by Kenneth Aruda, PhD and Jason Jardine here: https://lnkd.in/gqwdEK88 ? #KnobbeMartens #IPLaw #LifeSciences #Biotechnology

Congratulations to Knobbe Martens partner Irfan Lateef, who was recognized as a 2024 Los Angeles Times Business of Law Visionary for his outstanding work in intellectual property law. According to the publication, those honored as visionaries demonstrate “commitment to excellence, thought leadership and impactful contributions to both their clients and the broader legal community.” Irfan?was recognized for his nearly 25-year track record of achieving successful litigation outcomes for clients across multiple industries and in highly complex technical cases. The publication also highlighted Irfan’s key role on the team representing health technology company Masimo in several recent litigation matters. Read more and find his full profile here: https://lnkd.in/g425UHPG #KnobbeMartens #IPLaw

“Resolving Claim Construction Dispute at 12(b)(6) Stage May Be Error if Specification Indicates Claim Term Does Not Have its Plain Meaning.” Read our latest Litigation Blog post by Douglas Wentzel and Henry FitzGerald here: https://lnkd.in/gYrCiu4b #KnobbeMartens #IPLaw #Litigation

“The Intersection of FRAND Obligations and Anti-Suit Injunctions.” Read our latest Litigation Blog post by Brandon Smith and Zachary Grinovich here: https://lnkd.in/gei4vFiY #KnobbeMartens #IPLaw #Litigation

“New Tool From EPA, FDA, and USDA Guides Developers of Genetically Modified Microorganisms Through Regulatory Landscape.” Read our latest Life Sciences Blog post by Susan Janicki and Robert Hilton here: https://lnkd.in/gvUkrPWv #KnobbeMartens #IPLaw #LifeSciences #Biotechnology

We recently welcomed our new fall associate class to Knobbe Martens! Over the past few weeks, we published brief Q&As with some of our new associates, who shared a bit about their backgrounds, what attracted them to the firm, and what they enjoy doing outside of the office. Our final Q&A is with Oren Rosenberg, who is based in our Irvine office. Click below to learn about his career journey from biomedical engineering to intellectual property law. #KnobbeMartens #LifeAtKnobbe #IPLaw

In the Bloomberg Law article “FTC’s Marriott Data Breach Order Echoes States’ Right to Delete,” Knobbe Martens partner Mauricio Uribe offered his perspective on Federal and state privacy law compliance, specifically with regard to the potential to unify data privacy principles, such as the consumer right to delete data. Read more here: https://lnkd.in/gYcrqP7f #KnobbeMartens #IPLaw?